Oncogene - Table of Contents alert Volume 36 Issue 29

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 36, Issue 29 (July 2017) In this issue Original Articles Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Celebrating 30 years of Oncogene — 1987 to 2017 Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone.  Watch our anniversary video showing a brief impact overview >>>   Original Articles Top Iron addiction: a novel therapeutic target in ovarian cancer D Basuli, L Tesfay, Z Deng, B Paul, Y Yamamoto, G Ning, W Xian, F McKeon, M Lynch, C P Crum, P Hegde, M Brewer, X Wang, L D Miller, N Dyment, F M Torti and S V Torti Oncogene 2017 36: 4089-4099; advance online publication, March 20, 2017; 10.1038/onc.2017.11 Abstract | Full Text CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic OPEN A D Marshall, C G Bailey, K Champ, M Vellozzi, P O'Young, C Metierre, Y Feng, A Thoeng, A M Richards, U Schmitz, M Biro, R Jayasinghe, L Ding, L Anderson, E R Mardis and J E J Rasko Oncogene 2017 36: 4100-4110; advance online publication, March 20, 2017; 10.1038/onc.2017.25 Abstract | Full Text The drebrin/EB3 pathway drives invasive activity in prostate cancer OPEN A E Dart, D C Worth, G Muir, A Chandra, J D Morris, C McKee, C Verrill, R J Bryant and P R Gordon-Weeks Oncogene 2017 36: 4111-4123; advance online publication, March 20, 2017; 10.1038/onc.2017.45 Abstract | Full Text The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer V Thewes, R Simon, M Hlevnjak, M Schlotter, P Schroeter, K Schmidt, Y Wu, T Anzeneder, W Wang, P Windisch, M Kirchgäßner, N Melling, N Kneisel, R Büttner, U Deuschle, H P Sinn, A Schneeweiss, S Heck, S Kaulfuss, H Hess-Stumpp, J G Okun, G Sauter, A E Lykkesfeldt, M Zapatka, B Radlwimmer, P Lichter and M Tönjes Oncogene 2017 36: 4124-4134; advance online publication, March 20, 2017; 10.1038/onc.2017.32 Abstract | Full Text The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis M Zhou, M T S Mok, H Sun, A W Chan, Y Huang, A S L Cheng and G Xu Oncogene 2017 36: 4135-4149; advance online publication, March 20, 2017; 10.1038/onc.2017.38 Abstract | Full Text The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis M Sechler, J K Parrish, D K Birks and P Jedlicka Oncogene 2017 36: 4150-4160; advance online publication, March 20, 2017; 10.1038/onc.2017.44 Abstract | Full Text Compromised BRCA1–PALB2 interaction is associated with breast cancer risk T K Foo, M Tischkowitz, S Simhadri, T Boshari, N Zayed, K A Burke, S H Berman, P Blecua, N Riaz, Y Huo, Y C Ding, S L Neuhausen, B Weigelt, J S Reis-Filho, W D Foulkes and B Xia Oncogene 2017 36: 4161-4170; advance online publication, March 20, 2017; 10.1038/onc.2017.46 Abstract | Full Text Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1α axis OPEN Y Zhang, Y-J Ren, L-C Guo, C Ji, J Hu, H-H Zhang, Q-H Xu, W-D Zhu, Z-J Ming, Y-S Yuan, X Ren, J Song and J-M Yang Oncogene 2017 36: 4171-4181; advance online publication, March 20, 2017; 10.1038/onc.2017.51 Abstract | Full Text IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth C Jungnickel, L H Schmidt, L Bittigkoffer, L Wolf, A Wolf, F Ritzmann, A Kamyschnikow, C Herr, M D Menger, T Spieker, R Wiewrodt, R Bals and C Beisswenger Oncogene 2017 36: 4182-4190; advance online publication, March 27, 2017; 10.1038/onc.2017.28 Abstract | Full Text CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma Y Shang, J He, Y Wang, Q Feng, Y Zhang, J Guo, J Li, S Li, Y Wang, G Yan, F Ren, Y Shi, J Xu, N Zeps, Y Zhai, D He and Z Chang Oncogene 2017 36: 4191-4200; advance online publication, March 27, 2017; 10.1038/onc.2017.31 Abstract | Full Text MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation K Otsubo, H Goto, M Nishio, K Kawamura, S Yanagi, W Nishie, T Sasaki, T Maehama, H Nishina, K Mimori, T Nakano, H Shimizu, T W Mak, K Nakao, Y Nakanishi and A Suzuki Oncogene 2017 36: 4201-4211; advance online publication, March 27, 2017; 10.1038/onc.2017.58 Abstract | Full Text MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles W He, C Wang, R Mu, P Liang, Z Huang, J Zhang and L Dong Oncogene 2017 36: 4212-4223; advance online publication, March 27, 2017; 10.1038/onc.2017.62 Abstract | Full Text Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype X Guo, J L Koff, A B Moffitt, M Cinar, S Ramachandiran, Z Chen, J M Switchenko, M Mosunjac, S G Neill, K P Mann, M Bagirov, Y Du, Y Natkunam, H J Khoury, M R Rossi, W Harris, C R Flowers, I S Lossos, L H Boise, S S Dave, J Kowalski and L Bernal-Mizrachi Oncogene 2017 36: 4224-4232; advance online publication, April 3, 2017; 10.1038/onc.2017.90 Abstract | Full Text Corrigenda Top DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia OPEN H J Ferreira, H Heyn, M Vizoso, C Moutinho, E Vidal, A Gomez, A Martínez-Cardús, L Simó-Riudalbas, S Moran, E Jost and M Esteller Oncogene 2017 36: 4233; advance online publication, March 13, 2017; 10.1038/onc.2017.57 Full Text Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90-EGFR association Y-C Yang, T-Y Cheng, S-M Huang, C-Y Su, P-W Yang, J-M Lee, C-K Chen, M Hsiao, K-T Hua and M-L Kuo Oncogene 2017 36: 4234; advance online publication, March 20, 2017; 10.1038/onc.2017.18 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.